Advertisement

Grey matter structural differences in alcohol-dependent individuals with and without comorbid depression/anxiety—an MRI study

  • A. Uhlmann
  • B. Bandelow
  • D. J. Stein
  • S. Bloch
  • K. R. Engel
  • U. Havemann-Reinecke
  • Dirk WedekindEmail author
Original Paper

Abstract

Although depression and anxiety disorders are common comorbid conditions in alcohol dependence, few structural brain imaging studies have compared alcohol-dependent subjects with and without such comorbidity. In the current study, brain scans of 35 alcohol-dependent with and 40 individuals without diagnosis of a comorbid ICD-10 depressive or anxiety disorder receiving detoxification inpatient treatment were evaluated. Thickness and volumes of automatically segmented neuroanatomical structures were measured in FreeSurfer. Furthermore, associations of brain structure with biological markers and clinical severity markers of alcohol dependence were assessed. Despite comparable addiction severity, the non-comorbid group had evidence of higher cytotoxic effects of alcohol use on hepatic and haematological markers, and showed significantly smaller volumes of total cerebral, and cerebellar grey matter. Similarly, they showed unexpected smaller hippocampal and nucleus accumbens volumes, and thinner frontal, temporal and occipital cortices. Smaller brain volumes correlated with increased markers of hepatic and haematological dysfunction, and with longer duration of alcohol dependence in the non-comorbid group. Evidence of higher biomarkers of alcohol use may be indicative of more severe alcohol dependence or higher vulnerability to ethanol toxicity in this group. Furthermore, psychopathology-related drug treatment, which occurred in 53% of the comorbid group over the recent years, or tissue inflammation may have a moderate effect on the grade of cerebral atrophy in alcohol-dependent patients. Longitudinal studies are needed to investigate this issue more fully.

Keywords

Cortex Subcortical volumes Alcoholism Liver enzymes Erythrocyte measures 

Notes

Acknowledgements

This collaboration and research project was supported by the EUSARNAD program of the “European Commission 7th Framework Program” (Marie Curie International Research Staff Exchange Scheme Program).

Compliance with ethical standards

Conflict of interest

D. J. Stein has received research grants and/or consultancy honoraria from Abbott, ABMRF, Astrazeneca, Biocodex, Eli-Lilly, GlaxoSmithKline, Jazz Pharmaceuticals, Johnson & Johnson, Lundbeck, National Responsible Gambling Foundation, Novartis, Orion, Pfizer, Pharmacia, Roche, Servier, Solvay, Sumitomo, Sun, Takeda, Tikvah, and Wyeth. U. Havemann-Reinecke has received research grants and/or consultancy honoraria from CNMPB (Centre of nanomicroscopy and molecular biology of the Brain of the DFG, German research Federation), Astra Zeneca, Lundbeck, Lilly, Janssen. The other authors declare no conflict of interest with respect to subjects of the paper.

Supplementary material

406_2018_870_MOESM1_ESM.pdf (16 kb)
Supplementary material 1 (PDF 16 KB)

References

  1. 1.
    Laramée P, Kusel J, Leonard S, Aubin HJ, François C, Daeppen JB (2013) The economic burden of alcohol dependence in Europe. Alcohol Alcohol 48(3):259–269CrossRefGoogle Scholar
  2. 2.
    Wang YP, Andrade LH (2013) Epidemiology of alcohol and drug use in the elderly. Curr Opin Psychiatry 26(4):343–348CrossRefGoogle Scholar
  3. 3.
    Maimaris W, McCambridge J (2014) Age of first drinking and adult alcohol problems: systematic review of prospective cohort studies. J Epidemiol Community Health 68(3):268–274CrossRefGoogle Scholar
  4. 4.
    Monte SM de la, Kril JJ (2014) Human alcohol-related neuropathology. Acta Neuropathol 127:71–90CrossRefGoogle Scholar
  5. 5.
    Carlen PL, Wortzman G, Holgate RC, Wilkinson DA, Rankin JG (1978) Reversible cerebral atrophy in recently abstinent chronic alcoholics measured by computed tomography scans. Science 200:1076–1078CrossRefGoogle Scholar
  6. 6.
    Cala LA (1987) Is CT scan a valid indicator of brain atrophy in alcoholism? Acta Med Scand 221(S717):27–32CrossRefGoogle Scholar
  7. 7.
    Schroth G, Naegele T, Klose U, Mann K, Petersen D (1988) Reversible brain shrinkage in abstinent alcoholics, measured by MRI. Neuroradiology 30:121–126CrossRefGoogle Scholar
  8. 8.
    Maes M, Vandoolaeghe E, Degroote J, Altamura C, Roels C, Hermans P (2000) Linear CT-scan measurements in alcohol-dependent patients with and without delirium tremens. Alcohol 20(2):117–123CrossRefGoogle Scholar
  9. 9.
    Mann K, Ackermann B, Croissant B, Mundle G, Nakovics H, Diehl A (2005) Neuroimaging of gender differences in alcohol dependence: Are woman more vulnerable? Alcohol Clin Exp Res 29(5):896–901CrossRefGoogle Scholar
  10. 10.
    Bleich S, Sperling W, Degner D, Graesel E, Bleich K, Wilhelm J et al (2003) Lack of association between hippocampal volume reduction and first-onset alcohol withdrawal seizure. A volumetric MRI study. Alcohol Alcohol 38(1):40–44CrossRefGoogle Scholar
  11. 11.
    Chanraud S, Martelli C, Delain F, Kostogianni N, Douaud G, Aubin HJ et al (2007) Brain Morphometry and cognitive performance in detoxified alcohol-dependents with preserved psychosocial functioning. Neuropsychopharmacology 32(2):429–438CrossRefGoogle Scholar
  12. 12.
    Kril JJ, Halliday GM, Svoboda MD, Cartwright H (1997) The cerebral cortex is damaged in chronic alcoholics. Neuroscience 79(4):983–998CrossRefGoogle Scholar
  13. 13.
    Makris N, Oscar-Berman M, Kim S, Hodge SM, Kennedy DN, Caviness VS et al (2008) Decreased volume of the brain reward system in alcoholism. Biol Psychiatry 64(3):192–202CrossRefGoogle Scholar
  14. 14.
    Bühler M, Mann K (2011) Alcohol and the human brain: a systematic review of different neuroimaging methods. Alcohol Clin Exp Res 35(10):1771–1793CrossRefGoogle Scholar
  15. 15.
    Fortier CB, Leritz EC, Salat DH, Venne JR, Maksimovskiy AL, Williams V et al (2011) Reduced cortical thickness in abstinent alcoholics and association with alcoholic behavior. Alcohol Clin Exp Res 35(12):2193–2201CrossRefGoogle Scholar
  16. 16.
    Momenan R, Steckler LE, Saad ZS, van Rafelghem S, Kerich MJ, Hommer DW (2012) Effects of alcohol dependence on cortical thickness as determined by magnetic resonance imaging. Psychiat Res Neuroimaging 204(2–3):101–111CrossRefGoogle Scholar
  17. 17.
    Xiao P, Dai Z, Zhong J, Zhu Y, Shi H, Pan P (2015) Regional grey matter deficits in alcohol dependence: a meta-analysis of voxel based morphometry studies. Drug Alcohol Depend 153:22–28CrossRefGoogle Scholar
  18. 18.
    Yang X, Tian F, Zhang H, Zeng J, Chen T, Wang S, Jia Z, Gong Q (2016) Cortical and subcortical gray matter shrinkage in alcohol-use disorders: a voxel-based meta-analysis. Neurosci Biobehav Rev 66:92–103CrossRefGoogle Scholar
  19. 19.
    Fein G, Di Sclafani V, Cardenas VA, Goldmann H, Tolou-Shams M, Meyerhoff DJ (2002) Cortical gray matter loss in treatment-naive alcohol dependent individuals. Alcohol Clin Exp Res 26(4):558–564Google Scholar
  20. 20.
    Fein G (2013) Lifetime and current mood and anxiety disorders in short-term and long-term abstinent alcoholics. Alcohol Clin Exp Res 37(11):1930–1938CrossRefGoogle Scholar
  21. 21.
    Fein G (2015) Psychiatric comorbidity in alcohol dependence. Neuropsychol Rev 25(4):456–475CrossRefGoogle Scholar
  22. 22.
    Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL et al (1990) Comorbidity of mental disorders with alcohol and other drug abuse—results from the epidemiologic catchment area (ECA) study. JAMA 264(19):2511–2518CrossRefGoogle Scholar
  23. 23.
    Schneider U, Altmann A, Baumann M, Bernzen J, Bertz B, Bimber U et al (2001) Comorbid anxiety and affective disorder in alcohol dependent patients seeking treatment: the first multicentre study in Germany. Alcohol Alcohol 36(3):219–223CrossRefGoogle Scholar
  24. 24.
    Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W et al (2004) Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on alcohol and related conditions. Arch Gen Psychiatry 61:807–816CrossRefGoogle Scholar
  25. 25.
    Kushner MG, Sher KJ, Erickson DJ (1999) Prospective analysis of the relation between DSM-III anxiety disorders and alcohol use disorders. Am J Psychiatry 156(5):723–732Google Scholar
  26. 26.
    Sinha R, Robinson J, O´Malley S (1998) Stress response dampening: effects of gender and family history of alcoholism and anxiety disorders. Psychopharmacology 137:311–320CrossRefGoogle Scholar
  27. 27.
    Schuckit MA (2006) Comorbidity between substance use disorders and psychiatric conditions. Addiction 101(Suppl. 1):76–88CrossRefGoogle Scholar
  28. 28.
    Campbell S, Marriott M, Nahmias C, MacQueen GM (2004) Lower hippocampal volume in patients suffering from depression: meta-analysis. Am J Psychiatry 161(4):598–607CrossRefGoogle Scholar
  29. 29.
    Koolschijn PCMP., van Haren NEM, Lensvelt-Mulders GJLM., Hulshoff Pol HE, Kahn RS (2009) Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp 30:3719–3735CrossRefGoogle Scholar
  30. 30.
    Schmaal L, Veltman DJ, van Erp TG, Saemann PG, Frodl Jahanshad N (2016) Subcortical brain alterations in major depressive disorder: findings from the ENIGMA major depressive disorder working group. Mol Psychiatry 21(6):806–812CrossRefGoogle Scholar
  31. 31.
    Campbell S, MacQueen G (2006) An update on region brain volume differences associated with mood disorders. Curr Opin Psychiatry 19:25–33CrossRefGoogle Scholar
  32. 32.
    Grieve SM, Korgaonkar MS, Koslow SH, Gordon E, Williams LM (2013) Widespread reductions in grey matter volume in depression. Neuroimage Clin 3:332–339CrossRefGoogle Scholar
  33. 33.
    Brühl AB, Delsignore A, Komossa K, Weidt S (2014) Neuroimaging in social anxiety disorder—a meta-analytic review resulting in a new neurofunctional model. Neurosci Biobehav Rev 47:260–280CrossRefGoogle Scholar
  34. 34.
    Del Casale A, Serata D, Rapinesi C, Kotzalidis GD, Angeletti G, Tatarelli R et al (2013) Structural neuroimaging in patients with panic disorder: findings and limitations of recent studies. Psychiatr Danub 25(2):108–114Google Scholar
  35. 35.
    Radua J, Mataix-Cols D (2009) Voxel-wise meta-analysis of grey matter changes in obsessive–compulsive disorder. Br J Psychiatry 195:393–402CrossRefGoogle Scholar
  36. 36.
    Rotge JY, Langbour N, Guehl D, Bioulac B, Jaafari N, Allard M et al (2010) Gray matter alterations in obsessive–compulsive disorder: an anatomic likelihood estimation meta-analysis. Neuropsychopharmacology 35:686–691CrossRefGoogle Scholar
  37. 37.
    Goldstein RZ, Volkow ND (2002) Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159(10):1642–1652CrossRefGoogle Scholar
  38. 38.
    Gilpin NW, Herman MA, Roberto M (2015) The central amygdala as an integrative hub for anxiety and alcohol use disorders. Biol Psychiatry 77(10):859–869CrossRefGoogle Scholar
  39. 39.
    Miguel-Hidalgo JJ, Wei J, Andrew M, Overholser JC, Jurjus G, Stockmeier CA, Rajkowska G (2002) Glia pathology in the prefrontal cortex in alcohol dependence with and without depressive symptoms. Biol Psychiatry 52(12):1121–1133CrossRefGoogle Scholar
  40. 40.
    Sameti M, Smith S, Patenaude B, Fein G (2011) Subcortical volumes in long-term abstinent alcoholics: associations with psychiatric comorbidity. Alcohol Clin Exp Res 35(3):1067–1080CrossRefGoogle Scholar
  41. 41.
    Fein G, Shimotsu R, Chu R, Barakos J (2009) Parietal gray matter volume loss is related to spatial processing deficits in long-term abstinent alcoholic men. Alcohol Clin Exp Res 33:1806–1814CrossRefGoogle Scholar
  42. 42.
    Bleich S, Bandelow B, Javaheripour K, Müller A, Degner D, Wilhelm J et al (2003) Hyperhomocysteinemia as a new risk factor for brain shrinkage in patients with alcoholism. Neurosci Lett 335(3):179–182CrossRefGoogle Scholar
  43. 43.
    Crews FT, Nixon K (2009) Mechanisms of neurodegeneration and regeneration in alcoholism. Alcohol Alcohol 44:115–127CrossRefGoogle Scholar
  44. 44.
    Sutherland GT, Sheedy D, Sheahan PJ, Kaplan W, Kril JJ (2014) Comorbidities, confounders and the white matter transcriptome in chronic alcoholism. Alcohol Clin Exp Res 38(4):994–1001CrossRefGoogle Scholar
  45. 45.
    Chen C-H, Walker J, Momenan R, Rawlings R, Heilig M, Hommer DW (2012) Relationship between liver function and brain shrinkage in patients with alcohol dependence. Alcohol Clin Exp Res 36(4):625–632CrossRefGoogle Scholar
  46. 46.
    de Bruin EA, Lemmens PH, Hulshoff Pol HE, Verbaten MN, Kenemans JL (2012) Relationship between carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume levels and alcohol-related brain volume decreases in male drinkers. Hum Psychopharmacol 27(6):559–565CrossRefGoogle Scholar
  47. 47.
    WHO (World Health Organization) (1993) International classification of psychiatric disorders ICD-10. Chapter V (F), clinical diagnostic guidelines, 2nd edn; WHO, BernGoogle Scholar
  48. 48.
    Fischl B, Dale AM (2000) Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 97:11050–11055CrossRefGoogle Scholar
  49. 49.
    Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C et al (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33:341–355CrossRefGoogle Scholar
  50. 50.
    Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D et al (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31:968–980CrossRefGoogle Scholar
  51. 51.
    Benjamini Y, Krieger A, Yekutieli D (2006) Adaptive linear step-up procedures that control the false discovery rate. Biometrika 93:491–507CrossRefGoogle Scholar
  52. 52.
    Wang Q, Jie W, Liu JH, Yang JM, Gao TM (2017) An astroglial basis of major depressive disorder? An overview. Glia.  https://doi.org/10.1002/glia.23143
  53. 53.
    Rothermundt M, Arolt V, Peters M, Gutbrodt H, Fenker J, Kersting A, Kirchner H (2001) Inflammatory markers in major depression and melancholia. J Affect Disord 63(1–3):93–102CrossRefGoogle Scholar
  54. 54.
    Wedekind D, Neumann K, Falkai P, Malchow B, Engel KR, Jamrozinski K et al (2011) S100ß and homocysteine in the acute alcohol withdrawal syndrome. Eur Arch Psychiatry Clin Neurosci 261(2):133–138CrossRefGoogle Scholar
  55. 55.
    Davenport J (1996) Macrocytic anemia. Am Fam Physician 53(1):155–162Google Scholar
  56. 56.
    Di Benedetto B, Rupprecht R (2013) Targeting glia cells: novel perspectives for the treatment of neuropsychiatric diseases. Curr Neuropharmacol 11(2):171–185CrossRefGoogle Scholar
  57. 57.
    Sanacora G, Banasr M (2013) From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders. Biol Psychiatry 73(12):1172–1179CrossRefGoogle Scholar
  58. 58.
    Young LT (2002) Neuroprotective effects of antidepressant and mood stabilizing drugs. J Psychiat Neurosci 27(1):8–9Google Scholar
  59. 59.
    Durazzo TC1, Mon A, Gazdzinski S, Meyerhoff DJ (2013) Chronic cigarette smoking in alcohol dependence: associations with cortical thickness and N-acetylaspartate levels in the extended brain reward system. Addict Biol 18(2):379–391CrossRefGoogle Scholar
  60. 60.
    Franklin TR, Wetherill RR, Jagannathan K, Johnson B, Mumma J, Hager N et al (2014) The effects of chronic cigarette smoking on gray matter volume: influence of sex. Zang Y-F. ed. PLoS One 9(8):e104102CrossRefGoogle Scholar
  61. 61.
    Midanik L (1982) Over-reports of recent alcohol consumption in a clinical population: a validity study. Drug Alcohol Depend 9:101–110CrossRefGoogle Scholar
  62. 62.
    Del Boca FK, Noll JA (2000) Truth or consequences: the validity of self-report data in health services research on addictions. Addiction 95(Suppl 3):S347-S360Google Scholar
  63. 63.
    Babor TF, Steinberg K, Anton R, Del Boca F (2000) Talk is cheap: measuring drinking outcomes in clinical trials. J Stud Alcohol 61(1):55–63CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • A. Uhlmann
    • 1
    • 2
  • B. Bandelow
    • 3
  • D. J. Stein
    • 1
  • S. Bloch
    • 3
  • K. R. Engel
    • 3
  • U. Havemann-Reinecke
    • 3
    • 4
  • Dirk Wedekind
    • 3
    Email author
  1. 1.Department of Psychiatry and Mental HealthUniversity of Cape TownCape TownSouth Africa
  2. 2.Department of PsychiatryStellenbosch UniversityCape TownSouth Africa
  3. 3.Department of Psychiatry and Psychotherapy, University Medical CentreUniversity of GoettingenGöttingenGermany
  4. 4.Centre of Nanomicroscopy and Molecular Biology of the Brain, CNMPBGoettingen University Medical CentreGoettingenGermany

Personalised recommendations